BCL2 and head and neck squamous cell carcinoma: •In a retrospective HNSCC cohort, pre-treatment BCL2-positive tumors have shorter progression-free and overall survival and higher tumor recurrence rates when BCL2 status is analyzed by immunohistochemistry.